Literature DB >> 6099156

The binding of insulin-like growth factor II to the erythroleukemia cell line K562.

M Tally, X Z Tang, G Enberg, K Hall.   

Abstract

The erythroleukemia cell line K562 was previously shown to have specific binding sites for insulin but not for insulin-like growth factor I (IGF-I). In this study the presence of specific receptors for insulin-like growth factor II (IGF-II) is established. Scatchard analysis of the competition curve for IGF-II disclosed a non-cooperative binding kinetic with a calculated affinity constant 2.4 X 10(8) M-1 and a receptor number of 4.8 X 10(4) sites/cell. IGF-I displayed 10% crossreactivity over the IGF-II receptor but insulin did not crossreact at all. Instead insulin, present in high concentrations, enhanced the binding of IGF-II. The presence of IGF II but not IGF-I receptors makes the K562 cell line suitable for studying properties of the type-2 receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099156     DOI: 10.1007/bf01116701

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  3 in total

1.  Partial purification of an IGF-II receptor/binding protein from the erythroleukemia cell line K562.

Authors:  Q Zhang; K Hall; M Tally
Journal:  Mol Cell Biochem       Date:  1996-01-12       Impact factor: 3.396

2.  Determination of IGF-II levels in human serum using the erythroleukemia cell line K562.

Authors:  G L Spadoni; M Tally; K Florell; G Enberg; K Hall
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

3.  Insulin-like growth factor II signaling through the insulin-like growth factor II/mannose-6-phosphate receptor promotes exocytosis in insulin-secreting cells.

Authors:  Q Zhang; M Tally; O Larsson; R T Kennedy; L Huang; K Hall; P O Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.